The SIBERIA Trial (Acculink™ Versus CGuard™)

NCT03488199 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

NETWORK

Sponsor class

Conditions

Patients With Aterosclerotic Carotid Stenosis
Symptomatic Patients (Stenosis > 50%)
Asymptomatic Patients (Stenosis ≥80%)

Interventions

DEVICE: Stent Acculink ™
DEVICE: CGuardTM™

Sponsor

Meshalkin Research Institute of Pathology of Circulation